8/16/2022 | IGLM | GlaxoSmithKline to redeem notes from two series due 2023
|
4/14/2022 | IGLM | GlaxoSmithKline elects to redeem 2.875% notes due 2022 on May 1
|
3/21/2022 | IG | New Issue: GSK prices $8.75 billion of notes in seven tranches due 2024-2052 for Haleon spinoff
|
3/18/2022 | EUIG | Investor calls underway for spinoff megadeal of Haleon from GSK
|
3/18/2022 | IG | Market Commentary: Strong high-grade supply builds; Haleon in deal pipeline; new energy, financial paper tighter
|
3/17/2022 | BKIG | Moody's rates GSK Consumer/Haleon notes Baa1
|
3/17/2022 | BKIG | S&P gives BBB to GSK Consumer/Haleon notes
|
7/2/2021 | CVIG | Moody's moves GlaxoSmithKline view to stable
|
9/28/2020 | IG | New Issue: GlaxoSmithKline prices $1.25 billion of 0.534% three-year notes at 38 bps spread
|
9/28/2020 | IG | GlaxoSmithKline intends to price notes due 2023 via four bookrunners
|
6/17/2020 | CVIG | Moody’s assigns GSK Finance notes A2
|
4/7/2020 | IG | S&P trims GlaxoSmithKline
|
5/28/2019 | IG | Fitch lowers GlaxoSmithKline
|
3/19/2019 | IG | New Issue: GlaxoSmithKline Capital details $3.5 billion three-part sale of guaranteed notes
|
3/18/2019 | IG | Market Commentary: GlaxoSmithKline sells $3.5 billion notes; Target, SEB, utilities tap high-grade market
|
3/18/2019 | IG | New Issue: GlaxoSmithKline sells $3.5 billion of guaranteed notes in three parts
|
3/18/2019 | IG | Market Commentary: Morning Commentary: GlaxoSmithKline, Target, utilities to tap high-grade bond market
|
3/18/2019 | IG | GlaxoSmithKline Capital to price fixed- and floating-rate guaranteed notes in four tranches
|
12/21/2018 | IG | Moody's affirms GlaxoSmithKline
|
12/6/2018 | IG | S&P lowers GlaxoSmithKline to negative
|
12/6/2018 | IG | Moody's changes GlaxoSmithKline view to negative
|
5/11/2018 | IG | Market Commentary: Strong high-grade supply forecast; Vodafone, ASB plan roadshows; Petrofac markets notes
|
5/11/2018 | IG | Market Commentary: Morning Commentary: Investment-grade bond supply beats forecasts; inflows decline
|
5/11/2018 | IG | New Issue: GlaxoSmithKline prices $6 billion of notes in five tranches
|
5/10/2018 | IG | Market Commentary: Toyota, O’Reilly, Southern Gas price; HSBC, GlaxoSmithKline offer notes; Barclays improves
|
5/10/2018 | IG | Market Commentary: Morning Commentary: HSBC, GlaxoSmithKline, O’Reilly deals on tap; General Dynamics notes tighten
|
5/10/2018 | IG | GlaxoSmithKline intends to sell six tranches of dollar notes
|
4/11/2018 | IG | Fitch changes GlaxoSmithKline to negative
|
3/28/2018 | IG | Moody’s affirms GlaxoSmithKline
|
7/28/2017 | IG | Moody's changes outlook on GlaxoSmithKline to stable
|
5/27/2016 | IG | Fitch lowers GlaxoSmithKline
|
5/29/2015 | IG | S&P affirms GlaxoSmithKline
|
5/29/2015 | IG | Moody’s lowers GlaxoSmithKline view to negative
|
12/17/2014 | IG | Fitch lowers GlaxoSmithKline view to negative
|
8/1/2014 | IG | Moody’s lowers GlaxoSmithKline to A2
|
4/28/2014 | IG | S&P affirms GlaxoSmithKline
|
4/23/2014 | IG | Moody's could lower GlaxoSmithKline
|
7/29/2013 | IG | Moody's: GlaxoSmithKline view negative
|
3/14/2013 | IG | Market Commentary: Midday Commentary: Trading volume hits $2 billion as market mostly unchanged; Glaxo notes firm
|
3/13/2013 | IG | Market Commentary: GSK, Goldcorp, SEB bring bonds as issuance pace slows; recent deals mixed in secondary market
|
3/13/2013 | IG | New Issue: GlaxoSmithKline prices $3 billion of three-, 10-, 30-year notes
|
8/9/2012 | IG | Fitch affirms GlaxoSmithKline
|
5/4/2012 | IG | Market Commentary: Primary empties at end of $20 billion week; more to come; spreads widen; GE Capital weaker
|
5/2/2012 | IG | New Issue: GlaxoSmithKline prices $5 billion of notes in three tranches
|
5/2/2012 | IG | Market Commentary: GSK does massive trade alongside BP, WellPoint, Ericsson, Barclays; Ericsson comes in 15 bps
|
11/3/2011 | IG | Fitch: GlaxoSmithKline unaffected
|
8/11/2011 | IG | Fitch affirms GlaxoSmithKline
|
3/4/2011 | IG | GlaxoSmithKline files automatic shelf registration for debt securities
|
7/6/2010 | IG | Fitch affirms GlaxoSmithKline
|
2/18/2010 | IG | Moody's: GlaxoSmithKline view to stable
|
12/31/2009 | IG | Outlook 2010: Drug companies, money managers lead 2009's notable deals
|
6/15/2009 | IG | Market Commentary: Deutsche Telekom, Telecom Italia, Comcast price as telecoms fill primary; bonds trader lower
|
4/21/2009 | IG | Fitch cuts GlaxoSmithKline
|
2/19/2009 | IG | Market Commentary: New Roche bonds trade solidly higher; Snap-on prices two-part deal; CBS gains on debt-payment pledge
|
2/18/2009 | IG | Market Commentary: Roche sells mega deal, Canadian National Rail, Goodrich also price; DuPont new bonds widen
|
12/31/2008 | IG | Outlook 2009: Issuance forecast near 2008 level; price compromise seen for 2009; Glaxo, Altria deals notable
|
12/2/2008 | IG | Market Commentary: Citigroup, Goldman tap FDIC note program, Caterpillar, HP, ConEd price deals; spreads widen as Treasuries rally
|
5/30/2008 | IG | Market Commentary: National Bank of Greece issues, caps week of $16 billion, record May; supply, issuance dip as yields rise
|
5/29/2008 | IG | Market Commentary: Cox Communications, BMC Software, Rentenbank price; issuance, supply dwindle at end of record month
|
5/28/2008 | IG | Market Commentary: Telecom Italia, International Paper, Cardinal Health, Nucor, Italy, AmEx price; market weakens at close
|
5/16/2008 | IG | Market Commentary: Ontario, Starwood Hotels, JPMorgan, iStar price as week tops $35 billion; record May expected
|
5/15/2008 | IG | Market Commentary: Eaton, NiSource, Deutsche Bank, Harley Davidson, HBOS price; new issue premiums continue decrease
|
5/12/2008 | IG | Market Commentary: Petro-Canada, ACE INA, Centerpoint Energy, Simon Property, Harsco, price as spreads remain tight
|
5/7/2008 | IG | Market Commentary: JPMorgan, Merrill, KeyCorp, Colgate, Coca-Cola Enterprises, Hartford, Quebec price in steady conditions
|
5/6/2008 | IG | New Issue: GlaxoSmithKline prices upsized $9 billion in four tranches
|
5/6/2008 | IG | Market Commentary: GlaxoSmithKline prices year's biggest deal; Citigroup sells two; Berkshire Hathaway, TransAlta price
|
3/4/2008 | CVIG | GlaxoSmithKline files automatic shelf registration
|